6th Oct 2010 15:56
|
||||
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi |
||||
|
|
|||
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: |
Deltex Medical
|
|||
2 Reason for the notification (please tick the appropriate box or boxes): |
||||
An acquisition or disposal of voting rights |
Yes |
|||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
No |
|||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
No |
|||
An event changing the breakdown of voting rights |
No |
|||
Other (please specify): |
|
No |
||
3. Full name of person(s) subject to the notification obligation: |
Gartmore Investment Limited |
|||
4. Full name of shareholder(s) (if different from 3.): |
See attached schedule |
|||
5. Date of the transaction and date on which the threshold is crossed or reached: |
1st October 2010 |
|||
6. Date on which issuer notified: |
4th October 2010 |
|||
7. Threshold(s) that is/are crossed or reached: |
11% |
|||
8. Notified details: |
||||||||||||||||
A: Voting rights attached to shares |
||||||||||||||||
Class/type of shares if possible using the ISIN CODE |
Situation previous to the triggering transaction |
Resulting situation after the triggering transaction |
||||||||||||||
Number of Shares |
Number of Voting Rights |
Number of shares |
Number of voting rights |
% of voting rights |
||||||||||||
Direct |
Direct |
Indirect |
Direct |
Indirect |
||||||||||||
GB0059337583 |
14,003,111
|
14,003,111
|
14,278,111
|
|
14,278,111 |
|
10.960% |
|||||||||
|
||||||||||||||||
|
||||||||||||||||
B: Qualifying Financial Instruments |
||||||||||||||||
Resulting situation after the triggering transaction |
||||||||||||||||
Type of financial instrument |
Expiration date |
Exercise/ Conversion Period |
Number of voting rights that may be acquired if the instrument is exercised/ converted. |
% of voting rights |
||||||||||||
- |
- |
- |
- |
- |
||||||||||||
|
||||||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments |
||||||||||||||||
Resulting situation after the triggering transaction |
||||||||||||||||
Type of financial instrument |
Exercise price |
Expiration date |
Exercise/ Conversion period |
Number of voting rights instrument refers to
|
% of voting rights
|
|||||||||||
- |
- |
- |
- |
- |
Nominal |
Delta |
||||||||||
- |
- |
|||||||||||||||
|
||||||||||||||||
Total (A+B+C) |
||||||||||||||||
Number of voting rights |
Percentage of voting rights |
|||||||||||||||
14,278,111
|
10.960% |
|||||||||||||||
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: |
||
|
||
|
||
Proxy Voting: |
||
10. Name of the proxy holder: |
|
|
11. Number of voting rights proxy holder will cease to hold: |
|
|
12. Date on which proxy holder will cease to hold voting rights: |
|
|
|
||
13. Additional information: |
All figures are based on the Company's issued share capital of 130,273,003 as provided by Exshare
E mail contact [email protected] |
|
14. Contact name: |
RDU |
|
15. Contact telephone number: |
0207 782 2224 |
|
Related Shares:
Deltex Medical